Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response-Reference-Cited by-同舟云学术

Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response

Published:2014-09-29 Issue:29 Volume:34 Page:3860-3870
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Erin N,Podnos A,Tanriover G,Duymuş Ö,Cote E,Khatri I,Gorczynski R M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2014317.pdf

Reference54 articles.

1. Wright GJ, Puklavec MJ, Willis AC, Hoek RM, Sedgwick JD, Brown MH et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 2000; 13: 233–242.

2. Gorczynski R, Chen Z, Kai Y, Lee L, Wong S, Marsden PA . CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules. J Immunol 2004; 172: 7744–7749.

3. Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol 2003; 171: 3034–3046.

4. Boudakov I, Liu J, Fan N, Gulay P, Wong K, Gorczynski RM . Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-alpha and mixed leukocyte culture responses by CD200. Transplantation 2007; 84: 251–257.

5. Gorczynski RM, Chen Z, Hu J, Kai Y, Lei J . Evidence of a role for CD200 in regulation of immune rejection of leukaemic tumor cells in C57BL/6 mice. Clin Exp Immunol 2001; 126: 220–229.

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD200 depletion in glioma enhances antitumor immunity and induces tumor rejection;2024-09-10

2. Differential whole-genome doubling based signatures for improvement on clinical outcomes and drug response in patients with breast cancer;Heliyon;2024-04

3. Translation of Data from Animal Models of Cancer to Immunotherapy of Breast Cancer and Chronic Lymphocytic Leukemia;Genes;2024-02-25

4. ADAM10 and Neprilysin level decreases in immune cells of mice bearing metastatic breast carcinoma: Possible role in cancer inflammatory response;International Immunopharmacology;2024-01

5. SetQuence & SetOmic: Deep set transformers for whole genome and exome tumour analysis;Biosystems;2024-01